These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17064862)

  • 41. Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.
    Vaddi HK; Banks SL; Chen J; Hammell DC; Crooks PA; Stinchcomb AL
    J Pharm Sci; 2009 Aug; 98(8):2611-25. PubMed ID: 18972573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
    Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
    J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.
    Pillai O; Hamad MO; Crooks PA; Stinchcomb AL
    Pharm Res; 2004 Jul; 21(7):1146-52. PubMed ID: 15290853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis.
    Garnier T; Mäntylä A; Järvinen T; Lawrence MJ; Brown MB; Croft SL
    J Pharm Pharmacol; 2007 Jan; 59(1):41-9. PubMed ID: 17227619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action.
    Warner KS; Li SK; He N; Suhonen TM; Chantasart D; Bolikal D; Higuchi WI
    J Pharm Sci; 2003 Jun; 92(6):1305-22. PubMed ID: 12761819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of skin pretreatment with vehicle alone or drug in vehicle on flux of a subsequently applied drug: results of hairless mouse skin and diffusion cell studies.
    Sherertz EF; Sloan KB; McTiernan RG
    J Invest Dermatol; 1987 Sep; 89(3):249-52. PubMed ID: 3305716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, enzymatic hydrolysis and physico-chemical properties of N-substituted 4-(aminomethyl)benzoate diester prodrugs of ganciclovir.
    Jensen E; Bundgaard H
    Acta Pharm Nord; 1991; 3(4):243-7. PubMed ID: 1781915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design for optimized topical delivery: Prodrugs and a paradigm change.
    Sloan KB; Wasdo SC; Rautio J
    Pharm Res; 2006 Dec; 23(12):2729-47. PubMed ID: 17109215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species.
    Vávrová K; Lorencová K; Novotný J; Holý A; Hrabálek A
    Eur J Pharm Biopharm; 2008 Nov; 70(3):901-7. PubMed ID: 18675907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
    Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
    J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine.
    Furuishi T; Oda S; Saito H; Fukami T; Suzuki T; Tomono K
    Biol Pharm Bull; 2007 Jul; 30(7):1350-3. PubMed ID: 17603180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2006 Jun; 49(13):3948-54. PubMed ID: 16789751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of vehicle on the diffusion of salicylic acid through hairless mouse skin.
    Sloan KB; Siver KG; Koch SA
    J Pharm Sci; 1986 Aug; 75(8):744-9. PubMed ID: 3772744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of water solubility of solutes on their flux through human skin in vitro: an extended Flynn database fitted to the Roberts-Sloan equation.
    Thomas J; Majumdar S; Wasdo S; Majumdar A; Sloan KB
    Int J Pharm; 2007 Jul; 339(1-2):157-67. PubMed ID: 17412537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
    Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
    J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs.
    Al-Ghananeem AM; Traboulsi AA; Dittert LW; Hussain AA
    AAPS PharmSciTech; 2002; 3(1):E5. PubMed ID: 12919005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solubility and solution stability studies of different amino acid prodrugs of bromhexine.
    Aggarwal AK; Gupta M
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1319-27. PubMed ID: 22283553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin.
    Nam SH; Xu YJ; Nam H; Jin GW; Jeong Y; An S; Park JS
    Int J Pharm; 2011 Oct; 419(1-2):114-20. PubMed ID: 21807082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.